CI_with has_Ingredient has_MoA has_PE may_prevent may_treat drug associated with AE in adult drug associated with AE in pediatric used to treat disease Angiotensin-converting Enzyme Inhibitors [MoA] Angioedema [Disease/Finding] Arthritis, Rheumatoid [Disease/Finding] Bartter Syndrome [Disease/Finding] Diabetic Nephropathies [Disease/Finding] Drug Hypersensitivity [Disease/Finding] Edema [Disease/Finding] Heart Failure [Disease/Finding] Hyperaldosteronism [Disease/Finding] Hypertension, Malignant [Disease/Finding] Hypotension [Disease/Finding] Hypertrophy, Left Ventricular [Disease/Finding] Ventricular Dysfunction, Left [Disease/Finding] Decreased Bradykinin Degradation [PE] Decreased Intravascular Volume [PE] Decreased Mineralocorticoid Secretion [PE] Decreased Renal K+ Excretion [PE] Increased Renal Na+ Excretion [PE] Renal Arterial Vasodilation [PE] Pregnancy [Disease/Finding] ENALAPRIL MALEATE http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/018998s071lbl.pdf 9O25354EPJ Ingredient N0000146304 ENALAPRIL MALEATE <VANDF_Record>50.416^549^</VANDF_Record><VA_File>50.416</VA_File><VA_IEN>549</VA_IEN> Active C14204 Enalapril Maleate C0700452 4017954 203123 ENALAPRIL Decreased Blood Pressure [PE] Enalapril Maleate [Chemical/Ingredient] hypertension congestive heart failure headache AE dizziness AE cough AE syncope AE chest pain AE confusion AE hypotension AE nausea AE diarrhea AE vision blurred AE generalized muscle weakness AE